Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Sofinnova Partners
Entity

Sofinnova Partners

Tracked across 3 events · 34 articles · First seen Jul 05, 2026 · Last active Aug 07, 2026

Sentiment
27
Attention
6
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (3)
2 50
Business
Mironid raises $46M Series B
Mironid, a Glasgow-based biopharmaceutical company developing small molecule therapeutics for Autosomal Dominant Polycystic Kidney Disease (ADPKD), announced on August 5, 2026 that it raised $46 million in a Series B funding round. The round was…
Impact: Sofinnova Partners, an existing investor, participated in the round, affirming its belief in Mironid's potential.
Aug 05, 2026 · 7 articles
6 30
Business
Novartis Acquires Myricx Bio for $1.5B
Impact: Sofinnova Partners provided seed investment to Myricx Bio, supporting its initial stages of development.
Jul 05, 2026 · 21 articles
2 0
Business
Mission divests MTX652 to Dimerix
Impact: Investor in Mission.
Jul 17, 2026 · 6 articles
Key Actions (1)
70 Sofinnova Partners invested MironidMironid raises $46M Series B
ERGEN INTELLIGENCE
Track Sofinnova Partners live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.